Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eksp Klin Farmakol ; 67(3): 30-3, 2004.
Artigo em Russo | MEDLINE | ID: mdl-15341064

RESUMO

A series of four new furoxanopyrimidine derivatives was synthesized and studied with respect to antiulcerous, antisecretory, and antibacterial activity. Two compounds exhibit antiulcerous effect not accompanied (in contrast to the well-known H2 receptor blockers, quiditene, and other antiulcerous drugs) by inhibition of gastric acid secretion. No one of the studied compounds exhibited antibacterial activity in the tests with Helicobacter pylori.


Assuntos
Antiulcerosos/uso terapêutico , Oxidiazóis/farmacologia , Pirimidinas/farmacologia , Úlcera Gástrica/tratamento farmacológico , Animais , Relação Dose-Resposta a Droga , Mucosa Gástrica/efeitos dos fármacos , Mucosa Gástrica/metabolismo , Helicobacter pylori/efeitos dos fármacos , Masculino , Doadores de Óxido Nítrico/farmacologia , Ratos , Úlcera Gástrica/induzido quimicamente , Úlcera Gástrica/fisiopatologia
2.
Eksp Klin Farmakol ; 57(6): 36-8, 1994.
Artigo em Russo | MEDLINE | ID: mdl-7756958

RESUMO

Quiditene-(qunuclidyl-3)-di-(thyenel-2)carbinole hydrochloride was studied by using various experimental models. The agent was compared with H2-blockers. When gastrically used, quiditene in doses of 5-50 mg/kg dose-dependently decreased gastric acid secretion and prevented acute gastric mucosal lesions. As cimetidine and ranitidine, the agent accelerated chronic gastric ulcer healing. Quiditene has been allowed for clinical studies in Russia.


Assuntos
Antiulcerosos/farmacologia , Mucosa Gástrica/metabolismo , Quinuclidinas/farmacologia , Animais , Antiulcerosos/uso terapêutico , Doença Crônica , Cimetidina/farmacologia , Cimetidina/uso terapêutico , Avaliação Pré-Clínica de Medicamentos , Mucosa Gástrica/efeitos dos fármacos , Camundongos , Quinuclidinas/uso terapêutico , Ranitidina/farmacologia , Ranitidina/uso terapêutico , Ratos , Úlcera Gástrica/induzido quimicamente , Úlcera Gástrica/tratamento farmacológico , Úlcera Gástrica/etiologia , Estresse Fisiológico/complicações , Fatores de Tempo
3.
Eksp Klin Farmakol ; 56(1): 22-4, 1993.
Artigo em Russo | MEDLINE | ID: mdl-8100727

RESUMO

The effects of some antiallergic drugs on H1-histamine, 5-HT2-serotonin, and M-cholinoreceptors ligand binding in the rat brain were studied in vitro. Dimedrol, dimebon, and phencarol bonded to H1-receptors: IC50 were 76 +/- 10, 153 +/- 15, 320 +/- 60 nM, respectively. Diazoline and dimebon had some affinity for 5-HT2-receptors, its IC50 was 880 +/- 90 nM. Dimedrol, phencarol and diazoline were found to be active against M-cholinoceptors, but when given in the maximal concentration (10 microM) it acted nonspecifically. In contrast to the other drugs, bicarphen had no effects on the binding of [3H]-mepyramine, [3H]-ketanserine, and [3H]-quinuclidinyl benzylate in the rat brain.


Assuntos
Encéfalo/efeitos dos fármacos , Antagonistas dos Receptores Histamínicos H1/farmacologia , Antagonistas dos Receptores H2 da Histamina/farmacologia , Ketanserina/farmacocinética , Pirilamina/farmacocinética , Quinuclidinil Benzilato/farmacocinética , Animais , Encéfalo/metabolismo , Interações Medicamentosas , Ligantes , Masculino , Ratos , Ratos Sprague-Dawley , Receptores Histamínicos H1/efeitos dos fármacos , Receptores Histamínicos H1/metabolismo , Receptores Histamínicos H2/efeitos dos fármacos , Receptores Histamínicos H2/metabolismo , Receptores Muscarínicos/efeitos dos fármacos , Receptores Muscarínicos/metabolismo , Trítio
4.
Farmakol Toksikol ; 53(4): 21-3, 1990.
Artigo em Russo | MEDLINE | ID: mdl-1977614

RESUMO

The effect of an antiallergic (antihistaminic and antiserotonin) drug bicarphen on the functional state of the central nervous system (CNS) was studied. In experiments on animals bicarphen in contrast to dimedrol (diphenhydramine) exerted predominantly the activating effect on CNS (decreased the hypnotic action of barbamyl, enhanced the summation capacity of CNS and the activity of mice in the escape behavioral test, increased the bioelectrical activity of the brain and the activating effect of antidepressants on the EEG).


Assuntos
Sistema Nervoso Central/efeitos dos fármacos , Antagonistas dos Receptores Histamínicos H1/farmacologia , Quinuclidinas/farmacologia , Antagonistas da Serotonina/farmacologia , Animais , Antidepressivos/farmacologia , Encéfalo/efeitos dos fármacos , Encéfalo/fisiologia , Carbazóis/farmacologia , Carbolinas/farmacologia , Difenidramina/farmacologia , Interações Medicamentosas , Eletrofisiologia , Feminino , Masculino , Camundongos , Esforço Físico/efeitos dos fármacos , Coelhos
6.
Vrach Delo ; (10): 88-90, 1989 Oct.
Artigo em Russo | MEDLINE | ID: mdl-2575827

RESUMO

It was found that the new native antihistamine and antiserotonin drug bicarphen possesses in patients with allergic dermatoses (eczema and neurodermatitis) more active antihistaminic, anti-inflammatory, antipruritic and antiallergic properties than commonly used drugs, particularly in cases with prevalence of exudative and allergic reactions of the immediate type. Normalization of rosette-forming T-lymphocytes and A and G immunoglobulins was essential.


Assuntos
Dermatite Atópica/tratamento farmacológico , Antagonistas dos Receptores Histamínicos H1/uso terapêutico , Quinuclidinas/uso terapêutico , Antagonistas da Serotonina/uso terapêutico , Adolescente , Adulto , Formação de Anticorpos/efeitos dos fármacos , Formação de Anticorpos/imunologia , Dermatite Atópica/imunologia , Avaliação de Medicamentos , Quimioterapia Combinada , Feminino , Humanos , Imunidade Celular/efeitos dos fármacos , Imunidade Celular/imunologia , Masculino , Pessoa de Meia-Idade
7.
Farmakol Toksikol ; 52(5): 31-3, 1989.
Artigo em Russo | MEDLINE | ID: mdl-2480912

RESUMO

The effect of antihistaminics on contractions of the isolated guinea pig ureter was studied. The ureter contractions induced by histamine were prevented by H1-blockers: pipolphen (promethazine), dimedrol (diphenhydramine), phencarol (quifenadine), suprastin (chloropyramine), cyproheptadine and H2-blockers: cimetidine, ranitidine. Electric stimulation-induced contractions were prevented by suprastin. Phencarol, tavegil, cimetidine, ranitidine didn't act on the contractions. The electrically induced contractions were potentiated by pipolphen, dimedrol, cyproheptadine.


Assuntos
Antagonistas dos Receptores Histamínicos H1/farmacologia , Contração Muscular/efeitos dos fármacos , Ureter/efeitos dos fármacos , Animais , Relação Dose-Resposta a Droga , Estimulação Elétrica/métodos , Cobaias , Histamina/farmacologia , Liberação de Histamina/efeitos dos fármacos , Técnicas In Vitro , Ureter/fisiologia
8.
Biull Eksp Biol Med ; 106(8): 187-8, 1988 Aug.
Artigo em Russo | MEDLINE | ID: mdl-2458142

RESUMO

The effect of prazosin on epinephrine-induced contractions of human benign prostatic hyperplasia strips was studied. It was shown that prazosin has a pronounced adrenoblocking activity (EC50 = 5.10(-9) g/ml) but fails to affect strip contractions induced by KCL. It is suggested that prazosin can be used in the treatment of patients suffering from benign prostatic hyperplasia.


Assuntos
Prazosina/uso terapêutico , Hiperplasia Prostática/tratamento farmacológico , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Interações Medicamentosas , Humanos , Técnicas In Vitro , Masculino , Próstata/efeitos dos fármacos
12.
Biull Eksp Biol Med ; 95(5): 44-6, 1983 May.
Artigo em Russo | MEDLINE | ID: mdl-6133570

RESUMO

Experiments were made to study the influence of a new antihistaminic drug phencarol [(quinuclidyl-3) diphenylcarbinol hydrochloride] on gastric secretion in rats. Unlike the blockers of H1-histamine receptors (diphenhydramine, omeril, pyrilamine, and cyproheptadine), phencarol reduces secretion and the content of free hydrochloric acid in the gastric contents. The antacid activity of the drug is similar to that of the H2-receptor blocker, cimetidine. However, phencarol differs from the latter drug in the mechanism of action. The antacid action of phencarol is likely to be the result of its activation effect on diamine oxidase, which leads to a decrease in the content of active histamine in the tissues and diminution of its supply to H2-histamine receptors that control gastric secretion.


Assuntos
Mucosa Gástrica/metabolismo , Antagonistas dos Receptores Histamínicos H1/farmacologia , Animais , Compostos Benzidrílicos/farmacologia , Carbolinas/farmacologia , Cimetidina/farmacologia , Ciproeptadina/farmacologia , Difenidramina/farmacologia , Masculino , Pirilamina/farmacologia , Ratos
14.
Agents Actions ; 11(6-7): 685-92, 1981 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7340462

RESUMO

Treatment of bovine brain mitochondrial membranes with iproniazid (Ip) (1 mM, 15 min) inhibited monoamine oxidase (MAO) activity (substrates: 5-hydroxytryptamine, tyramine, dopamine) and significantly (about 7-fold) increased histamine deaminating activity (HDA). A selective inhibitor of MAO-A clorgyline (contrary to deprenyl) prevented the increase in HDA. Ip (200 mg/kg; within 10-16 h after parenteral administration) markedly (about 6-fold) increased the level of the HDA) in brain mitochondria of mice and guinea pigs. At the same time, a decrease in content of histamine (Hi) and increase in content of 5-hydroxytryptamine was noted in the brains of mice. In anesthetized and non-anesthetized guinea pigs Ip decreased (or prevented) the bronchoconstriction and toxic effects caused by Hi. The antihistamine effects of Ip are apparently due to its being able to induce reversible qualitative alteration (transformation) of the catalytic activity of the membrane-bound MAO of type A, which acquires as a result of this transformation potent HDA.


Assuntos
Encéfalo/enzimologia , Mitocôndrias/enzimologia , Monoaminoxidase/metabolismo , Animais , Bovinos , Dopamina/metabolismo , Histamina/metabolismo , Antagonistas dos Receptores Histamínicos/farmacologia , Técnicas In Vitro , Iproniazida/farmacologia , Cinética , Masculino , Camundongos , Serotonina/metabolismo , Tiramina/metabolismo
15.
Biull Eksp Biol Med ; 91(3): 340-2, 1981 Mar.
Artigo em Russo | MEDLINE | ID: mdl-6113860

RESUMO

The effect of new antihistaminic drugs, phencarol and bicarphen, on immunologic reactivity of experimental animals was studied in comparison with diphenhydramine. Phencarol and bicarphen inhibited the delayed type allergic reactions to a greater degree than diphenydramine. Unlike diphenhydramine, phencarol and bicarphen injected simultaneously with test-antigen markedly decreased the number of rosette-forming lymphocytes in the immunocompetent organs (spleen, thymus, lymph nodes). Phencarol, bicarphen and diphenhydramine produced the same inhibitory effect on the content of antibody-producing cells in the spleen of mice.


Assuntos
Compostos Benzidrílicos/farmacologia , Difenidramina/farmacologia , Antagonistas dos Receptores Histamínicos H1/farmacologia , Imunidade/efeitos dos fármacos , Imunossupressores , Quinuclidinas/farmacologia , Animais , Formação de Anticorpos/efeitos dos fármacos , Dinitroclorobenzeno , Cobaias , Hipersensibilidade Tardia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Formação de Roseta
16.
Farmakol Toksikol ; 43(2): 148-53, 1980.
Artigo em Russo | MEDLINE | ID: mdl-6108233

RESUMO

The new antihistaminic and antiallergic drug phencarol (quinuclidy-3-diphenylcarbinol hydrochloride) in contradistinction to dimedrol (diphenhydramine) and diprazine (promethazin) exerts no pronounced depressant effect on the central nervous system. It does not significantly influence the period of action of hypnotic drugs, the effects produced by alcohol, spontaneous motor activity, summation capacity of the central nervous system, conditioned reflexes or electroencephalogram. That phencarol possesses no marked central action may be accounted for by its low lipophilic activity and little permeability of the blood brain barrier by this drug.


Assuntos
Compostos Benzidrílicos/farmacologia , Sistema Nervoso Central/efeitos dos fármacos , Antagonistas dos Receptores Histamínicos H1/farmacologia , Quinuclidinas/farmacologia , Animais , Encéfalo/efeitos dos fármacos , Gatos , Depressão Química , Cães , Avaliação Pré-Clínica de Medicamentos , Interações Medicamentosas , Eletroencefalografia , Cobaias , Camundongos , Ratos
17.
Farmakol Toksikol ; 43(1): 36-41, 1980.
Artigo em Russo | MEDLINE | ID: mdl-6103819

RESUMO

In experiments in vivo, the derivatives of quinuclidylarylcarbinol, possessing an antihistaminic activity, fencarol, its di(o-tolyl)- and di(o-methoxyphenyl)-derivatives activate histamine oxidative deamination by diaminoxidase of the rat lungs and increase the histamine tissue level. Quinuclidyl-3-dithienyl carbinol inhibits the activity of diaminoxidase, but decreases the histamine tissue level. On the contrary, dimedrol (diphenhydramine), pipolfen (promethazin), pyrilamine and cyproheptadin exerted no effect on the activity of diaminoxidase or the histamine tissue level. All the compounds studied did not alter oxidative deamination of the rat brain serotonin by monoamine oxidase or the serotonin content in brain tissues.


Assuntos
Compostos Benzidrílicos/farmacologia , Antagonistas dos Receptores Histamínicos H1/farmacologia , Oxirredutases atuantes sobre Doadores de Grupo CH-NH/metabolismo , Piperidinas/farmacologia , Quinuclidinas/farmacologia , Animais , Encéfalo/efeitos dos fármacos , Desaminação , Ativação Enzimática/efeitos dos fármacos , Histamina/metabolismo , Pulmão/efeitos dos fármacos , Masculino , Psicotrópicos/farmacologia , Ratos , Serotonina/metabolismo , Fatores de Tempo
19.
Biull Eksp Biol Med ; 86(10): 471-4, 1978 Oct.
Artigo em Russo | MEDLINE | ID: mdl-81693

RESUMO

Phenothiazines (chlorpromazine and promethazine) and antihistaminic quinuclidine derivatives [phencarol, quinuclidyl-3-di-(o-tolyl) carbinol, hydrochloride quinuclidyl-3-di-(o-methoxyphenyl) carbinol--HQMC] at concentrations preceding the histamine-releasing ones inhibited the compound 48/80-induced histamine release from the isolated rat mast cells. HQMC inhibited histamine release induced by selective liberators (compound 48/80, MCD-peptide, specific antigen), but potentiated histamine release induced by nonselective liberators (chlorpromazine, tryton X-100). The inhibition by HQMC of histamine release induced by compound 48/80 increased during 1 min and was reversible. The inhibitory effect of all the compounds tested was partially counteracted by glucose.


Assuntos
Antagonistas dos Receptores Histamínicos/administração & dosagem , Antagonistas dos Receptores Histamínicos H1/farmacologia , Liberação de Histamina/efeitos dos fármacos , Mastócitos/efeitos dos fármacos , Quinuclidinas/farmacologia , p-Metoxi-N-metilfenetilamina/antagonistas & inibidores , Animais , Compostos Benzidrílicos/farmacologia , Clorpromazina/farmacologia , Interações Medicamentosas , Feminino , Mastócitos/metabolismo , Peptídeos/farmacologia , Polietilenoglicóis/farmacologia , Prometazina/farmacologia , Ratos
20.
Farmakol Toksikol ; 41(3): 279-83, 1978.
Artigo em Russo | MEDLINE | ID: mdl-26596

RESUMO

As evidenced no less than 45 per cent of tritium-labelled antihistaminic drug phencarol (quinuclidine-3-diphenylcarbinol hydrochloride) introduced intragastrically to rats is absorbed. The maximal radioactivity in various organs is reached in 1--3 hours, with high specific radioactivity being recorded in the lungs and liver and low--in the brain. The drug or radioactive products of its tranformation are eliminated largely via the gastrointestinal tract and kidneys.


Assuntos
Antagonistas dos Receptores Histamínicos H1/farmacologia , Quinuclidinas/farmacologia , Animais , Compostos Benzidrílicos/metabolismo , Compostos Benzidrílicos/farmacologia , Biofarmácia , Antagonistas dos Receptores Histamínicos H1/metabolismo , Absorção Intestinal/efeitos dos fármacos , Cinética , Masculino , Quinuclidinas/metabolismo , Ratos , Fatores de Tempo , Trítio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...